An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Completed

Phase 3 Results

Summary of Purpose

The purpose of this study is to compare the efficacy and safety of rivaroxaban with warfarin for the prevention of blood clots in the brain (referred to as stroke) and blood clots in other parts of the body referred to as non-central nervous system systemic embolism) in patients with non-valvular atrial fibrillation (a heart rhythm disorder).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 January 2013.

1 Dec 2006 23 Nov 2006 1 Sep 2010 1 Sep 2010 1 Jan 2013 2 Dec 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Christopher C. Nessel, MD (+)1-888-84 22937 clinical-trials-contact@bayerhealthcare.com

    clinical-trials-contact@bayerhealthcare.com